PRRT and OCLU Improved Progression-Free Survival for Pancreatic Cancer
mohamed_hassan / Pixabay

PRRT and OCLU Improved Progression-Free Survival for Pancreatic Cancer

Are there therapeutic options for patients living with unresectable (inoperable) pancreatic cancer? According to an article in MedScape, researchers sought to understand whether sunitinib or a combination of peptide receptor…

Continue Reading PRRT and OCLU Improved Progression-Free Survival for Pancreatic Cancer